Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia
Despite vast improvements in the treatment of Philadelphia chromosome-positive chronic
myeloid leukemia (CML) in chronic phase (CP), advanced stages of CML, accelerated …
myeloid leukemia (CML) in chronic phase (CP), advanced stages of CML, accelerated …
[HTML][HTML] Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and …
Abstract The EUTOS Long-Term Survival score was tested in 350 children with chronic
myeloid leukemia in first chronic phase treated with imatinib and registered in the …
myeloid leukemia in first chronic phase treated with imatinib and registered in the …
Can prognostic scoring systems for chronic myeloid leukemia as established in adults be applied to pediatric patients?
In contrast to adult medicine, specific scoring systems predicting the treatment response for
an individual pediatric patient (pt) with chronic myeloid leukemia (CML) have not yet been …
an individual pediatric patient (pt) with chronic myeloid leukemia (CML) have not yet been …
[HTML][HTML] Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era—experience from a tertiary …
LC Kuntegowdanahalli, GB Kanakasetty… - …, 2016 - ncbi.nlm.nih.gov
Chronic myeloid leukaemia (CML) is a myeloproliferative disorder. Over the years many
prognostic models have been developed to better risk stratify this disease at baseline. Sokal …
prognostic models have been developed to better risk stratify this disease at baseline. Sokal …
[HTML][HTML] Risk stratification of chronic myeloid leukemia according to different prognostic scores
J Aijaz, N Junaid, MA Naveed, R Maab - Cureus, 2020 - ncbi.nlm.nih.gov
Methods This study was conducted at King Edward Medical University from January 2013 to
May 2019. A total of 114 patients were diagnosed with CML in the chronic phase during the …
May 2019. A total of 114 patients were diagnosed with CML in the chronic phase during the …
Early and sustained deep molecular response achieved with nilotinib in high Sokal risk chronic myeloid leukemia patients
U Zaidi, B Kaleem, M Borhany, S Maqsood… - Cancer management …, 2019 - Taylor & Francis
Background Nilotinib (Tasigna®) is a second-generation tyrosine kinase inhibitor that shows
faster and deeper molecular responses (MR) in comparison to Imatinib as initial therapy in …
faster and deeper molecular responses (MR) in comparison to Imatinib as initial therapy in …
Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience)
R Ben Lakhal, H Ghedira, H Bellaaj, Y Ben Youssef… - Annals of …, 2018 - Springer
Data are limited in developing countries regarding the clinicopathologic features and
response to therapy of chronic myeloid leukemia (CML) in the era of imatinib (IM). The …
response to therapy of chronic myeloid leukemia (CML) in the era of imatinib (IM). The …
Chronic myeloid leukemia in Nigerian patients: Anemia is an independent predictor of overall survival
AA Oyekunle, MA Durosinmi… - Clinical Medicine …, 2016 - journals.sagepub.com
Objectives The advent of the tyrosine kinase inhibitors has markedly changed the prognostic
outlook for patients with Ph+ and/or BCR-ABL1+ chronic myeloid leukemia (CML). This …
outlook for patients with Ph+ and/or BCR-ABL1+ chronic myeloid leukemia (CML). This …
Response to imatinib therapy in adult patients with chronic myeloid leukemia in Saudi population: a single-center study
E Alsobhi, MB Abrar, M Abdelaal, A Alsaeed… - Leukemia & …, 2015 - Taylor & Francis
No study has been published yet in the Arab world regarding response and outcome of
imatinib in patients with chronic myeloid leukemia (CML). This study evaluated a total of 122 …
imatinib in patients with chronic myeloid leukemia (CML). This study evaluated a total of 122 …
[PDF][PDF] The utility and applicability of chronic myeloid leukemia scoring systems for predicting the prognosis of Egyptian patients on Imatinib: retrospective study
TA Elbedewy, HE Elashtokhy - J Leuk, 2016 - researchgate.net
Background: Chronic myeloid leukemia (CML) is myeloproliferative clonal neoplasm.
Imatinib has greatly improved CML prognosis. Many prognostic scoring systems have been …
Imatinib has greatly improved CML prognosis. Many prognostic scoring systems have been …